Breast cancer screening by mammography in Norway. Is it cost-effective?

Annals of Oncology

Volumn 10, Issue 2, 1999, Pages 197-203

  Norum, J ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

Breast cancer; Cost effectiveness; Mammography; Screening

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; NORWAY; PRIORITY JOURNAL;

EID: 0033058224     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008376608270     Document Type: Article

References (39)

1. Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care 1991; 7: 604-15.
2. Collette HJA, Rombach JJ, Day NE, de Waard F. Evaluation of screening for breast cancer in a non-randomised study (the DOM project) by means of a case-control study. Lancet 1984; 1: 1224-6.
3. Verbeek ALM, Hendriks JHCL, Holland R et al. Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975 1981. Lancet 1984; 1: 1222-4.
4. UK trial of Early Detection of Breast Cancer Group. First results on mortality reduction in the UK trial of Early Detection of Breast Cancer. Lancet 1988; 1: 411-6.
5. Andersson I, Aspergren K, Janzon L et al. Mammographic screening and mortality from breast cancer. The Malmö mammographic screening trial. BMJ 1988; 297: 943-8.
6. Roberts MM, Alexander FE, Anderson TJ et al. Edinburgh trial of screening for breast cancer. Mortality at seven years. Lancet 1990; 335: 241-6.
7. Rutquist LE, Miller AB, Andersson I et al. Reduced breast cancer mortality with mammography screening, an assessment of currently available data. Int J Cancer 1990; 5: 76-84.
8. Tabar L, Fagerberg CJG, Gad A et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1: 829-32.
9. van Ineveld BM, van Oortmarssen GJ, de Koning HJ et al. How cost-effective is breast cancer screening in different EC countries? Eur J Cancer 1993; 29A: 1663-8.
10. The Norwegian Mammography Screening Project. The annual report for 1996. Oslo: The National Health Administration 1997.
11. Cancer in Norway 1994. Oslo: The Cancer Registry of Norway. Institute for Epidemiological Cancer Research 1997.
12. Norwegian Breast Cancer group (NBCG). Breast cancer, diagnosis and treatment. Oslo: The Norwegian Cancer Union 1994.
13. Norwegian Public Reports. NOU 1987;7. Oslo: The National Health Administration 1987.
14. Luce BR, Elixhasuer A. Standards for the Socioeconomic Evaluation of Health Care Services. Berlin: Springer 1990.
15. Walter SD, Day NE. Estimation of the duration of a pre-clinical disease state using screening data. Am J Epidemiol 1983; 118: 865-86.
16. Beemsterboer PMM, de Koning HJ, Warmerdam PG et al. Prediction of the effects and costs of breast-cancer screening in Germany. Int J Cancer 1994; 58: 623-8.
17. Moskowitz M, Fox SH. Cost analysis of aggressive breast cancer screening. Radiology 1979; 130: 253-6.
18. Norum J, Wist E. Breast cancer treated at the University hospital of Tromsø Norway, 1986 1994. J Norwegian Med Assoc 1997; 117: 3786-9.
19. The National Health Administration. The DRG system. Price list and codes for 1997. HCFA-12. Oslo: The National Health Administration 1997.
20. Norum J. Is breast conserving surgery cost-effective? Breast Cancer Treat Res 1997; 45: 7-14.
21. Zalcberg JR, Siderov J, Simes J. The role of 5-fluorouracil dose in the adjuvant therapy of colorectal cancer. Ann Oncol 1996; 7: 41-6.
22. The tariff of public out-patient treatment valid from July 1st 1997. Oslo: National Health Administration 1997.
23. Plans P, Casademont L, Salleras L. Cost-effectiveness of breast cancer screening in Spain. Int J Technol Assess Health Care 1996; 12: 146-50.
24. Gad A, Thomas BA, Moskowitz M. Screening for breast cancer in Europe: Achievements, problems and the future. Recent Results Cancer Res 1984; 90: 179-94.
25. Miller AB, Howe GR, Wall C. The national study of breast cancer screening. Clin Invest Med 1982; 4: 227-58.
26. Sickles EA. Screening for breast cancer with mammography. Clin Imaging 1991; 15: 253-60.
27. de Koning HJ, van Ineveld BM, van Oortmarssen GJ et al. Breast cancer screening and cost-effectiveness, policy alternatives, quality of life considerations and the possible impact of uncertain factors. Int J Cancer 1991; 49: 531-7.
28. Lundgren B. Screening in breast cancer. A view from the front line. Biomed Pharmacother 1988; 42: 443-6.
29. Nyström L, Rutqvist LE, Wall S et al. Breast cancer screening with mammography. Overview of Swedish randomised trials. Lancet 1993; 341: 973-8.
30. Kingsmore DB, Hole D, Gillis CR, George WD. Can population based screening reduce the mortality from breast cancer? Eur J Cancer 1998; 34 (Suppl 5): 92.
31. Fletcher RH. Screening for colorectal cancer. Weighing the alternatives. In Perry MC, Whippen D (eds): American Society of Clinical Oncology Educational Book, 33rd Annual Meeting. Alexandria, VA: American Society of Clinical Oncology 1997: 200-4.
32. Khullar SK, DiSario JA, Colon cancer screening. Sigmoidoscopy or colonoscopy. Gastrointest Enclosc Clin N Am 1997; 7: 365-86.
33. Norum J, Angelsen V, Wist E, Olsen JA. Treatment costs in Hodgkin's disease. A cost-utility analysis. Eur J Cancer 1996; 32A: 1510-7.
34. Gelfand DW, Colorectal cancer. Screening strategies. Radiol Clin North Am 1997; 35: 431-8.
35. Brown ML. Screening for colorectal cancer. N Engl J Med 1993; 329: 1352-3.
36. Atkin WS, Cuzick J, Northover JMA, Whynes DK. Prevention of colorectal cancer by once-only sigmoidoscopy. Lancet 1993; 341: 736-40.
37. Ransohoff DF, Lang CA. Cost-effectiveness of one-time colonoscopy screening to reduce colorectal cancer mortality. Gastroenterology 1994: 106 (Suppl): A24 (Abstr).
38. Tengs TO, Adams M, Pliskin J et al. Five hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995; 15: 369-90.
39. van Ballegooijen M, Habbema JDF, van Oortmarssen GJ et al. Preventive papsmears, striking the balance between costs, risks and benefits. Br J Cancer 1992; 65: 930-3.